| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.03M | - | |
| VP | 141.5K | $11.32M | - | |
| Other | 87.3K | $6.98M | - | |
| VP | 73.6K | $5.89M | -15,000 | |
| CFO | 70.1K | $5.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2022 | Jaw Ching47 | SVP Finance &CFO | Sale+OE | 15,000 | $38.00 | $570,000.00 | -18.3% | +8.8% | -3.3% | |
| Mar 2, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $36.31 | $363,136.00 | -2.3% | +6.0% | +5.2% | |
| Mar 2, 2022 | Costa Santo J | Director | Sale+OE | 10,000 | $37.35 | $373,477.00 | -66.7% | +6.0% | +5.2% | |
| Feb 16, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $36.50 | $364,967.00 | -2.7% | +14.8% | +20.2% | |
| Feb 7, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $33.86 | $338,594.00 | -2.7% | +0.1% | +28.7% | |
| Dec 27, 2021 | Wierenga Wendall59 | Director | Sale+OE | 4,166 | $44.37 | $184,854.17 | -38.1% | -19.8% | -1.4% | |
| Dec 27, 2021 | Smith Sandford D48 | Director | Sale+OE | 28,290 | $45.79 | $1,295,399.10 | -58.2% | -19.8% | -1.4% | |
| Dec 23, 2021 | Kaye Edward M. Md46 | Director | Sale+OE | 15,000 | $45.00 | $675,000.00 | -68.9% | -16.7% | +2.1% | |
| Dec 9, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 29,166 | $36.49 | $1,064,287.76 | -8.9% | +8.8% | +2.1% | |
| Nov 19, 2021 | Smith Sandford D48 | Director | Sale+OE | 29,032 | $41.21 | $1,196,275.17 | -58.9% | -13.8% | +0.7% |